eflornithine has been researched along with Helicobacter Infections in 2 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Helicobacter Infections: Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wilson, KT | 2 |
Barry, DP | 1 |
Asim, M | 1 |
Leiman, DA | 1 |
de Sablet, T | 1 |
Singh, K | 1 |
Casero, RA | 1 |
Chaturvedi, R | 1 |
2 other studies available for eflornithine and Helicobacter Infections
Article | Year |
---|---|
Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection.
Topics: Antineoplastic Agents; Eflornithine; Helicobacter Infections; Helicobacter pylori; Humans; Stomach N | 2019 |
Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction.
Topics: Animals; Antigens, Bacterial; Bacterial Proteins; Cells, Cultured; Eflornithine; Enzyme Inhibitors; | 2011 |